Netherlands (NL)

Efficacy of Upadacitinib Dose Escalation in a Phase 3 Long-Term Extension Ulcerative Colitis Study (2022) Panaccione R, Long M, Ran Z, Atreya R, Nakase H, Zhou W, Yao X, et al. Conference contribution The development of the Physical Activity Environment Policy Index (PA-EPI): a tool for monitoring and benchmarking government policies and actions to improve physical activity (2022) Woods C, Kelly L, Volf K, Gelius P, Messing S, Forberger S, Lakervele J, et al. Conference contribution Reducing the return of avoidance and fear by directly targeting avoidance: Comparing incentive-based and instructed extinction of avoidance to passive fear extinction (2022) Pittig A, Wong AHK Journal article Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial (2022) Rader F, Kirtane AJ, Wang Y, Daemen J, Lurz P, Sayer J, Saxena M, et al. Journal article Usage-based approaches to child code-switching: State of the art and ways forward (2022) Gaskins D, Quick AE, Verschik A, Backus A Journal article, Review article A deep spectromorphological study of the γ -ray emission surrounding the young massive stellar cluster Westerlund 1 (2022) Aharonian F, Ashkar H, Backes M, Martins VB, Becherini Y, Berge D, Bi B, et al. Journal article Risk of pelvic metastasis and significance of pelvic lymphadenectomy in patients with node-positive vulvar cancer - results of the AGO-VOP.2/QS vulva study (2022) Jaeger A, Hampl M, Zu Eulenburg C, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Conference contribution Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol (2022) Mikolaizak AS, Rochester L, Maetzler W, Sharrack B, Demeyer H, Mazzà C, Caulfield B, et al. Journal article Orbital Decay in M82 X-2 (2022) Bachetti M, Heida M, Maccarone T, Huppenkothen D, Israel GL, Barret D, Brightman M, et al. Journal article Exploring preferences of at-risk individuals for preventive treatments for rheumatoid arthritis (2022) Simons G, Bywall KS, Englbrecht M, Johansson EC, Disantostefano RL, Radawski C, Veldwijk J, et al. Journal article